These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17339583)

  • 1. Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis.
    Forman MS; Mufson EJ; Leurgans S; Pratico D; Joyce S; Leight S; Lee VM; Trojanowski JQ
    Neurology; 2007 Mar; 68(10):757-63. PubMed ID: 17339583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.
    Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H
    Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease.
    Leinonen V; Koivisto AM; Savolainen S; Rummukainen J; Tamminen JN; Tillgren T; Vainikka S; Pyykkö OT; Mölsä J; Fraunberg M; Pirttilä T; Jääskeläinen JE; Soininen H; Rinne J; Alafuzoff I
    Ann Neurol; 2010 Oct; 68(4):446-53. PubMed ID: 20976765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
    Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
    Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex.
    Winton MJ; Joyce S; Zhukareva V; Practico D; Perl DP; Galasko D; Craig U; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 May; 111(5):401-12. PubMed ID: 16609851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated cortical zinc in Alzheimer disease.
    Religa D; Strozyk D; Cherny RA; Volitakis I; Haroutunian V; Winblad B; Naslund J; Bush AI
    Neurology; 2006 Jul; 67(1):69-75. PubMed ID: 16832080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent accumulations of tau and amyloid beta-protein in the human entorhinal cortex.
    Katsuno T; Morishima-Kawashima M; Saito Y; Yamanouchi H; Ishiura S; Murayama S; Ihara Y
    Neurology; 2005 Feb; 64(4):687-92. PubMed ID: 15728293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains.
    Zhou XW; Li X; Bjorkdahl C; Sjogren MJ; Alafuzoff I; Soininen H; Grundke-Iqbal I; Iqbal K; Winblad B; Pei JJ
    Neurobiol Dis; 2006 Jun; 22(3):657-68. PubMed ID: 16513361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.
    Deramecourt V; Bombois S; Maurage CA; Ghestem A; Drobecq H; Vanmechelen E; Lebert F; Pasquier F; Delacourte A
    J Neuropathol Exp Neurol; 2006 Mar; 65(3):278-88. PubMed ID: 16651889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.
    Bennett DA; Schneider JA; Wilson RS; Bienias JL; Arnold SE
    Arch Neurol; 2004 Mar; 61(3):378-84. PubMed ID: 15023815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic appraisal using immunohistochemistry of brain pathology in aged and demented subjects.
    Aho L; Parkkinen L; Pirttila T; Alafuzoff I
    Dement Geriatr Cogn Disord; 2008; 25(5):423-32. PubMed ID: 18391488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study.
    Li G; Sokal I; Quinn JF; Leverenz JB; Brodey M; Schellenberg GD; Kaye JA; Raskind MA; Zhang J; Peskind ER; Montine TJ
    Neurology; 2007 Aug; 69(7):631-9. PubMed ID: 17698783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia.
    Kövari E; Gold G; Herrmann FR; Canuto A; Hof PR; Bouras C; Giannakopoulos P
    Neurology; 2007 Mar; 68(12):927-31. PubMed ID: 17372128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease.
    Ikonomovic MD; Abrahamson EE; Isanski BA; Wuu J; Mufson EJ; DeKosky ST
    Arch Neurol; 2007 Sep; 64(9):1312-7. PubMed ID: 17846271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease.
    Tremblay C; Pilote M; Phivilay A; Emond V; Bennett DA; Calon F
    J Alzheimers Dis; 2007 Dec; 12(4):377-90. PubMed ID: 18198424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice.
    Rezai-Zadeh K; Arendash GW; Hou H; Fernandez F; Jensen M; Runfeldt M; Shytle RD; Tan J
    Brain Res; 2008 Jun; 1214():177-87. PubMed ID: 18457818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment.
    Mufson EJ; Chen EY; Cochran EJ; Beckett LA; Bennett DA; Kordower JH
    Exp Neurol; 1999 Aug; 158(2):469-90. PubMed ID: 10415154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.